Cargando…

Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene

OBJECTIVE: To explore the mechanism of miR-195-5p in the pathogenesis non-small cell lung cancer (NSCLC) and cisplatin resistance. METHODS: The function of miR-195-5p in NSCLC and cisplatin resistance were determined by MTT, scratch assay, transwell assay, and nude mice xenograft experiments. miR-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hao, Sui, Zhi-lin, Wu, Xian-xian, Tang, Peng, Zhang, Hong-dian, Yu, Zhen-tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092352/ https://www.ncbi.nlm.nih.gov/pubmed/33953601 http://dx.doi.org/10.2147/PGPM.S302755

Ejemplares similares

Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer
por: Ye, Rui, et al.
Publicado: (2017)

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
por: Liu, Chunhui, et al.
Publicado: (2015)

Decrease of miR-195 Promotes Chondrocytes Proliferation and Maintenance of Chondrogenic Phenotype via Targeting FGF-18 Pathway
por: Wang, Yong, et al.
Publicado: (2017)

miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC
por: Jiang, Zeyong, et al.
Publicado: (2014)

Oncomirs miRNA-221/222 and Tumor Suppressors miRNA-199a/195 Are Crucial miRNAs in Liver Cancer: A Systematic Analysis
por: Li, Yanhu, et al.
Publicado: (2016)

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
por: Zang, Shuzhi, et al.
Publicado: (2019)

CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging
por: Zhang, Tao, et al.
Publicado: (2021)

SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling
por: Chen, Tai-yu, et al.
Publicado: (2022)

Expression of Concern: miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC
Publicado: (2019)

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
por: Chen, Xuesong, et al.
Publicado: (2016)

Expression levels of serum miRNA-195 in different types of patients with cholangiocarcinoma and its value to determine the prognosis thereof
por: Chen, Qingliang, et al.
Publicado: (2018)

Cisplatin chemotherapy-induced miRNA-210 signaling inhibits hepatocellular carcinoma cell growth
por: Yu, Huan, et al.
Publicado: (2019)

MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
por: Cheng, Zhenshun, et al.
Publicado: (2014)

miRNA-195 expression in the tumor tissues of female Brazilian breast cancer patients with operable disease
por: de Sales, Alexandre Cesar Vieira, et al.
Publicado: (2021)

MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2
por: Yin, Yali, et al.
Publicado: (2017)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
por: Cirilo, Priscila Daniele Ramos, et al.
Publicado: (2017)

Clinicopathological features associated to MiRNA-195 expression in patients with breast cancer: Evidence of a potential biomarker
por: Nadeem, Farkhunda, et al.
Publicado: (2017)

Circulating miRNA-195-5p and -451a in Patients with Acute Hemorrhagic Stroke in Emergency Department
por: Giordano, Mauro, et al.
Publicado: (2022)

miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase
por: Liu, Zhiwen, et al.
Publicado: (2021)

Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
por: Ballas, Marc S, et al.
Publicado: (2011)

Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1
por: Duan, Lincan, et al.
Publicado: (2022)

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
por: Iaboni, Margherita, et al.
Publicado: (2016)

Expression profile of miRNA in NSCLC tissues in middle-altitude area
por: Gu, Yuhai, et al.
Publicado: (2020)

High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer
por: Yi, Minhan, et al.
Publicado: (2021)

Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis
por: Yang, Bingsheng, et al.
Publicado: (2021)

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN
por: Yu, Tao, et al.
Publicado: (2015)

Circulating MiRNA-195-5p and -451a in Transient and Acute Ischemic Stroke Patients in an Emergency Department
por: Giordano, Mauro, et al.
Publicado: (2019)

Inhaled Cisplatin for NSCLC: Facts and Results
por: Kosmidis, Christoforos, et al.
Publicado: (2019)

Robust expression of tumor suppressor miRNA’s let-7 and miR-195 detected in plasma of Saudi female breast cancer patients
por: Qattan, Amal, et al.
Publicado: (2017)

Hypoxia-induced miR-27 and miR-195 regulate ATP consumption, viability, and metabolism of rat cardiomyocytes by targeting PPARγ and FASN expression
por: Lin, Jintuan, et al.
Publicado: (2021)

Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma
por: Sun, Tianhao, et al.
Publicado: (2022)

LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC
por: Liu, Dongcheng, et al.
Publicado: (2022)

Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p
por: Zhou, Lili, et al.
Publicado: (2020)

CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis
por: Zhang, Zhi-ye, et al.
Publicado: (2020)

Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review
por: Samarth, Nikhil, et al.
Publicado: (2022)

Circulating MiRNA-195-5p and -451a in Diabetic Patients with Transient and Acute Ischemic Stroke in the Emergency Department
por: Giordano, Mauro, et al.
Publicado: (2020)

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
por: Lin, Zhilai, et al.
Publicado: (2020)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma, Yuzhu, et al.
Publicado: (2019)

hsa_circ_0013401 Accelerates the Growth and Metastasis and Prevents Apoptosis and Autophagy of Neuroblastoma Cells by Sponging miR-195 to Release PAK2
por: Zhu, Shibo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3l07j95658o52k60c58cqes9j7